We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Las Vegas Sands
LVS
$32B
| $96.6M | 0.24% |
2,121,936
+81,638
| +4% | +$3.84M |
|
102
Thermo Fisher Scientific
TMO
$215B
| $95.4M | 0.24% |
263,340
-18,440
| -7% | -$6.18M |
|
103
Crown Castle
CCI
$33.6B
| $93.4M | 0.23% |
558,391
-11,558
| -2% | -$1.86M |
|
104
Enbridge
ENB
$121B
| $92.5M | 0.23% |
3,039,336
-132,299
| -4% | -$4.06M |
|
105
Goldman Sachs
GS
$292B
| $92.2M | 0.23% |
466,557
-15,475
| -3% | -$2.9M |
|
106
Tyler Technologies
TYL
$14.2B
| $91.3M | 0.23% |
263,350
-21,949
| -8% | -$7.37M |
|
107
KKR & Co
KKR
$89.4B
| $89.8M | 0.22% |
2,907,188
-49,936
| -2% | -$1.34M |
|
|
CTLT
108
DELISTED
CATALENT, INC.
CTLT
| $88.4M | 0.22% |
1,206,528
+653,043
| +118% | +$44.3M |
|
109
Etsy
ETSY
$8.06B
| $87.9M | 0.22% |
827,341
+167,010
| +25% | +$12.4M |
|
110
Trex
TREX
$4.39B
| $86.9M | 0.22% |
1,336,030
-94,280
| -7% | -$5.03M |
|
111
Danaher
DHR
$142B
| $86.3M | 0.21% |
550,753
+98,241
| +22% | +$14.1M |
|
112
Corcept Therapeutics
CORT
$9.98B
| $85.7M | 0.21% |
5,094,181
-122,651
| -2% | -$1.72M |
|
113
Alnylam Pharmaceuticals
ALNY
$38.4B
| $85.4M | 0.21% |
576,469
-15,547
| -3% | -$2.1M |
|
114
HDFC Bank
HDB
$122B
| $84.9M | 0.21% |
3,736,106
+715,288
| +24% | +$14.7M |
|
115
Repligen
RGEN
$7.08B
| $84.6M | 0.21% |
684,325
+46,449
| +7% | +$5.46M |
|
116
Planet Fitness
PLNT
$4.43B
| $84.3M | 0.21% |
1,392,025
+178,390
| +15% | +$10.7M |
|
|
EVBG
117
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $83.7M | 0.21% |
605,279
-159,779
| -21% | -$20.8M |
|
118
Eagle Materials
EXP
$6.72B
| $83.7M | 0.21% |
1,191,789
+135,951
| +13% | +$8.55M |
|
119
Yeti Holdings
YETI
$3.84B
| $83.2M | 0.21% |
1,946,957
+180,450
| +10% | +$5.42M |
|
120
Vulcan Materials
VMC
$37.6B
| $83.1M | 0.21% |
717,099
-88,667
| -11% | -$9.71M |
|
121
Marvell Technology
MRVL
$150B
| $83M | 0.21% |
2,368,172
-80,084
| -3% | -$2.34M |
|
|
122
Kimberly-Clark
KMB
$37.4B
| $82.9M | 0.21% |
586,726
-1,344,724
| -70% | -$186M |
|
123
CALL
Invesco QQQ Trust
QQQ
$439B
| $81.7M | 0.2% |
+330,000
| New | +$74M |
|
124
Advanced Micro Devices
AMD
$704B
| $81.3M | 0.2% |
1,545,576
-43,134
| -3% | -$2.29M |
|
125
CRISPR Therapeutics
CRSP
$4.64B
| $79.2M | 0.2% |
1,078,000
| – | – |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.